Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer

Clinical trial NCT02846792 · TERMINATED

Trial details

NCT number: NCT02846792
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ALK Gene Translocation EGFR Activating Mutation Recurrent Non-Small Cell Lung Carcinoma ROS1 Gene Translocation Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7

Start date: 2017-06-14
Primary completion: 2018-07-12
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.